Abstract CT172: A phase 2 multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent metastatic or persistent cervical carcinoma

Amir Jazaeri; Robert Edwards; Robert Wenham; Koji Matsuo; Gini F Fleming; David M O'Malley; Brian Slomovitz; Bradley Monk; Robert J Brown; Sam Suzuki; Igor Gorbatchevsky; Maria Fardis; Emese Zsiros

doi:10.1158/1538-7445.AM2018-CT172

Back

Abstract CT172: A phase 2 multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent metastatic or persistent cervical carcinoma

Journal article

Peer reviewed

Abstract CT172: A phase 2 multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent metastatic or persistent cervical carcinoma

Amir Jazaeri, Robert Edwards, Robert Wenham, Koji Matsuo, Gini F Fleming, David M O'Malley, Brian Slomovitz, Bradley Monk, Robert J Brown, Sam Suzuki, …

Cancer research (Chicago, Ill.), Vol.78(13 Supplement), pp.CT172-CT172

2018-07-01

DOI: https://doi.org/10.1158/1538-7445.AM2018-CT172

Metrics

4 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Abstract CT172: A phase 2 multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent metastatic or persistent cervical carcinoma
Creators: Amir Jazaeri
Robert Edwards
Robert Wenham
Koji Matsuo
Gini F Fleming
David M O'Malley
Brian Slomovitz
Bradley Monk
Robert J Brown
Sam Suzuki
Igor Gorbatchevsky
Maria Fardis
Emese Zsiros
Publication Details: Cancer research (Chicago, Ill.), Vol.78(13 Supplement), pp.CT172-CT172
Academic Unit: Miller School of Medicine; UMMG Dept of Obstetrics & Gynecology
Language: English
Resource Type: Journal article
Record Identifier: 991031598995202976